EGFR and c-Met-fibronectin type III domain binding molecules

Monospecific and bispecific EGFR and/or c-Met FN3 domain containing molecules, isolated nucleotides encoding the molecules, vectors, host cells, and methods of making thereof are useful in the generation of therapeutic molecules and treatment and diagnosis of diseases and disorders.

Saved in:
Bibliographic Details
Main Authors Jacobs, Steven, Klein, Donna, Diem, Michael, Anderson, Mark, Picha, Kristen, Attar, Ricardo, Moores, Sheri, King, Alastair, Hyun, Linus, O'Neil, Karyn
Format Patent
LanguageEnglish
Published 10.12.2020
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:Monospecific and bispecific EGFR and/or c-Met FN3 domain containing molecules, isolated nucleotides encoding the molecules, vectors, host cells, and methods of making thereof are useful in the generation of therapeutic molecules and treatment and diagnosis of diseases and disorders.
Bibliography:Application Number: AU20200267284